干白素-17D减轻OVA诱导的气道炎症和重塑部分通过CD93受体

Shuochuan Shi1, Jintao Zhang1, Yun Pan1

  • 1Department of Respiratory, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Institute of Respiratory Diseases, Featured Laboratory of Respiratory Immunology and Regenerative Medicine in Universities of Shandong, Jinan Clinical Research Center for Respiratory Disease, Jinan, China.

概括

干白素-17D (IL-17D) 缺乏会使喘恶化,而IL-17D的使用会减少气道炎症和重塑. 这种细胞因子可能为喘管理提供一个新的治疗点.